维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Schnackenberg CG"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Development of a small-molecule serum-and glucocorticoid-regulated kinase-1 an- tagonist and its evaluation as a prostate cancer therapeutic 显示文摘	Sherk AB Frigo DE Schnackenberg CG	2008	Cancer Res2008，68，18：	1
2	Physiological and pathophysiogical roles of oxygen radicals in the renal microvasculature显示文摘	Schnackenberg CG Christine G	2002	Am J Physiol Regul Integr Comp Physiol2002，282，2：	1
3	PPARδ activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure显示文摘	Jucker BM Doe CP Schnackenberg CG	2007	J Cardiovasc Pharmacol2007，50，1：	1
4	Insulin-induced sodium retention is not enhanced by the thiazolidinedione,rosiglitazone显示文摘	Schnackenberg CG Wade-Whittaker FM Buckingham RE	2001	J Am Soc NePhrol2001，12，3：	1
5	11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome显示文摘	Schnackenberg CG	2008	Curt Opin Investig Drugs2008，9，3：	1
6	Physiological and pathophysialogical roles of oxygen radicals in the renal microvasculature 显示文摘	Schnackenberg CG	2002	Am J Physiol Regul Integr Comp Physiol2002，282，2：	1
7	Chronic inhi-bition of 11 p -hydroxysteroid dehydrogenase type 1 activity de-creases hypertension,ipsulin resistance,and hypertriglyceridemiain metabolic syndrome 显示文摘	Schnackenberg CG Costell MH Krosky DJ	2013	Biomed Res Int2013，2013，42：	1
8	Normalizeation of blood pressure and renal vascular resistance in SHR with a-memebrane-permeable superoxide dismutase mimetic: role of nitric oxide显示文摘	Schnackenberg CG Welch WJ Wilcox CS	1998	Hypertension1998，32，：	1
9	Oxygen radicals in cardiovascular-renal dis- ease 显示文摘	Schnackenberg CG	2002	Curr Opin Pharmacol2002，2，2：	1
10	Oxygen radicals in cardiovascular -renal disease显示文摘	Schnackenberg CG	2002	Curr Opin Pharmacol2002，2，：	1
11	显示文摘	Schnackenberg CG Wilcox CS	1999	Hypertension1999，33，：	1
12	Chronic inhibi- tion of 11 beta - hydroxysteroid dehydrogenaee type 1 activity decreases hypertension, insulin resistance, and hypertriglyceri- demia in metabolic syndrome显示文摘	Schnackenberg CG Costell MH Krosky D J	2013	Biomed Res Int2013，2013，42：	1
13	Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature显示文摘	Schnackenberg CG	2002	Am J Physiol Regul Integr Comp Physiol2002，282，2：	1
14	Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature显示文摘	Schnackenberg CG	2002	Am J Physiol Regul Integr Comp Physiol2002，282，2：	1
15	Two week administration of tempol attenuatesboth hypertension and renal excretion of 8-iso-prostaglandin f2alpha显示文摘	Schnackenberg CG Wilcox CS	1998	Hypertension1998，33，12：	1
16	Oxygen radicals in cardiovascular-renal disease显示文摘	Schnackenberg CG	2002	Curr Opin Pharmacol2002，2，2：	1
17	Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature显示文摘	Schnackenberg CG		0，，02：	1
18	Effects of angiotensins II and IV on blood pressure, renal function, and PAH expression in the heart and kidney of the rat 显示文摘	Abrahamsen CT Pullen MA Schnackenberg CG	2003	Pharmacology2003，66，2：	1
19	Physiological and patho-physiological roles of oxygen radicals in therenal microvasculature显示文摘	Schnackenberg CG	2002	Am J Physiol Integr Comp Physiol2002，282，：	1
20	Normalization of blood pressure and renal vascular resistance in SHR with a membrane - perme- able superoxide dismutase mimetic: role of nitric oxide 显示文摘	Schnackenberg CG Welch WJ Wilcox CS	1998	Hyperten- sion1998，32，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示